Access to this symposium requires KEY ZONE access (paid registration)
to HDCN. For information about subscribing to HDCN, please go to this link.
|
|
 |
Can Pharmacologic Interventions Prevent or Treat Acute Renal Failure?
Richard Lafayette, MD |
|
Assessment of Renal Function in Chronic Liver Disease
Isaac Teitelbaum, MD |
|
Treatement of Focal Glomerulosclerosis (FSGS)
Gerald B. Appel, MD |
|
CPC: The Nephrotic
Syndrome
Julie Lin, MD, MPH |
|
Dialysis
Trials in Acute Renal failure: What Have We Learned?
Jonathan Himmelfarb, MD |
|
Keeping
Your Water Safe
Jim Curtis, CHT |
|
Defining
Acute Kidney Failure - ADQI
John A. Kellum, MD |
|
Hepatitis C
Virus-Associated Kidney Disease
David Roth, MD |
|
Nutrition Across
the Continuum of Care in Kidney Disease
Judith Beto, PhD, RD, FADA |
|
Glomerulonephritis:
The Deposition Diseases Part 1 of 2
Stephen Korbet, MD |
|
Part 2 of
2
Stephen Korbet, MD |
|
Introduction
to Laboratory Values
James Zazra, PhD |
|
System Barriers
to Creating the Best Angioaccess for Our Patients
Jeffrey Sands, MD |
|
Please see individual lecture pages.
|
 |
Gerald Appel, MD
Professor of Clinical Medicine
Director of Clinical Nephrology
Columbia University
Judith Beto, PhD, RD, FADA
Research Associate in Nephrology and Hypertension
Loyola University Medical Center, Maywood, IL
Chair of Nutrition Sciences
Dominican University, River Forest, IL
Jim Curtis, CHT
Area Manager
Fresenius Medical Services; Lexington, MA
Jonathan Himmelfarb, MD
Director, Division of Nephrology and Renal Transplantation
Maine Medical Center
Portland, ME
John Kellum, MD
Associate Professor Critical Care Medicine and Medicine.
University of Pittsburg School of Medicine
Pittsburg, PA
Stephen Korbet, MD
Professor of Medicine at Rush Medical College
Associate Director of the Section of Nephrology at Rush-Presbyterian-St.
Luke’s Medical Center
Chicago, IL.
Richard A. Lafayette, MD
Associate Professor of Medicine
Clinical Chief, Division of Nephrology,
Stanford University School of Medicine,
Stanford, CA.
Julie Lin, MD, MPH
Instructor in Medicine, Harvard Medical School; Associate Physician, Renal Division, Brigham and Women's Hospital; Boston, MA.
David Roth, MD
Section Head of Nephrology
Professor of Medicine
University of Miami Jackson Memorial Hospital; Miami, FL
Jeffrey Sands, MD
Vice President of Medical Technologies
Fresenius Medical Care NA; Lexington, MA
Isaac Teitelbaum, MD
Professor of Internal Medicine
Director of Home Dialysis
University of Colorado Health Sciences Center; Denver, CO
James Zazra, Ph.D.
Director of Clinical Trials Services at Spectra Renal Management,
Fresenius Medical Care NA; Lexington, MA
|
|
 |
This
talk was CME accredited at the time it was given. However
no credit is available for this web version.
Please see individual lecture pages.
|
SPEAKER DISCLOSURE STATEMENT : |
Dr. Appel discloses no apparent conflicts of interest
pertaining to the material discussed in this talk.
Dr. Beto discloses no apparent conflicts of interest pertaining
to the material discussed in this talk.
Mr. Curtis discloses no apparent conflicts of interest pertaining
to the material discussed in this talk.
Dr. Himmelfarb discloses no apparent conflicts of interest
pertaining to the material discussed in this talk.
Dr. Kellum discloses no apparent conflicts of interest pertaining
to the material discussed in this talk.
Dr. Korbet discloses no apparent conflicts of interest pertaining
to the material discussed in this talk.
Dr. Lafayette discloses no apparent conflicts of interest pertaining
to the material discussed in this talk.
Dr. Lin discloses no apparent conflicts of interest pertaining
to the material discussed in this talk.
Dr. Roth discloses no apparent conflicts ofinterest pertaining
to the material discussed in this talk.
Dr. Sands is an employee of Fresenius Medical Care NA.
Dr. Teitelbaum discloses no apparent conflicts ofinterest pertaining
to the material discussed in this talk.
Dr. Zazra is an employee of Fresenius Medical Care NA. |
| |
